Haemophagocytic lymphohistiocytosis has variable time to onset following CD19 chimeric antigen receptor T cell therapy
- PMID: 31410842
- DOI: 10.1111/bjh.16155
Haemophagocytic lymphohistiocytosis has variable time to onset following CD19 chimeric antigen receptor T cell therapy
Keywords: chimeric antigen receptor T cell therapy; cytokine release syndrome; haemophagocytic lymphohistiocytosis.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources